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Pathologic differentiation between lupus and nonlupus membranous
glomerulopathy. The following clinical and pathologic features were
evaluated in 170 patients with electron microscopically documented
membranous glomerulopathy: age, sex, race, American Rheumatism
Association lupus criteria, serum ANA, serum complement, glomerular
hypercellularity, stage of subepithelial dense deposits, endothelial
tubuloreticular inclusions, tubular basement membrane deposits, tissue
ANA, glomerular deposition of IgG, 1gM, IgA, C3, C4, and Clq. At the
time of biopsy 148 patients had no clinical evidence for lupus, and 22
had a clinical diagnosis of lupus. Six additional patients eventually
developed overt lupus after an average of 12 months. Incidences of
serologic and pathologic features in lupus as compared with nonlupus
membranous glomerulopathy were determined. These data were used
to calculate sensitivity, specificity, positive and negative predictive
values, and overall efficiency of each parameter in differentiating
between lupus and nonlupus membranous glomerulopathy. In general,
serologic, morphologic and immunohistopathologic features are more
accurate at ruling out lupus than making the diagnosis of lupus.
However, a number of features are significantly more frequent in lupus
membranous glomerulopathy. Therefore, identification of these fea-
tures, especially more than one, warrants a high suspicion of lupus
rather than nonlupus membranous glomerulopathy even in patients
without clinically overt systemic lupus erythematosus. The positive/ne-
gative predictive values of some of the pathologic features studied are
as follows: mesangial dense deposits 63/99, subendothelial dense depos-
its 77/93, tubuloreticular inclusions 61/96, intense CIq deposition 47/95,
tubular basement membrane deposits 100/87, and glomerular hypercel-
lularity 26/86.
Differentiation pathologique entre glomérulopathie extra-membraneuse
lupique et non lupique. Les caractCristiques cliniques et pathologiques
suivantes ont été évaluCes chez 170 malades atteints de glomerulopathie
extra-membraneuse documentée par microscopic électronique: l'age, Ic
sexe, Ia race, les critCres de lupus de l'American Rheumatism Associa-
tion, les ANA seriques, Ic complement sérique, l'hypercellularite
glomCrulaire, Ic stade des dCpôts denses sous-epithCliaux, les inclusions
endothCliales tubuloréticulaires, les depots dans Ia membrane basale
tubulaire, les ANA tissulaires, les depOts glomCrulaires d'IgG, 1gM,
IgA, C3, C4, et Clq. Au moment de Ia biopsie, 148 malades n'avaient
pas d'argument clinique pour un lupus, et 22 avaient un diagnostic
clinique de lupus. Six malades supplémentaires ont dCveloppé un lupus
patent aprCs une moyenne de 12 mois. L'incidence des caractCristiques
serologiques et pathologiques dans Ia glomerulopathie extra-membran-
euse lupique ou non lupique a été déterminée. Ces donnCes ont été
utilisCes pour calculer Ia sensibilité, Ia spécificité, les valeurs prédic-
tives positives et negatives, et l'efficacité globale de chaque paramétre
pour différencier entre glomerulopathie extramembraneuse lupique ou
non lupique. D'une facon générale, les caractéristiques serologiques,
morphologiques et immunohistopathologiques sont plus puissantes
pour éliminer le lupus que pour faire Ic diagnostic de lupus. Cependant,
un certain nombre de caracteristiques sont significativement plus
frequentes dans Ia glomerulopathie extra-membraneuse lupique. C'est
pourquoi Ia misc en evidence de ces caractéristiques, surtout s'il y en a
plus dune, apporte une forte suspicion de glomérulopathie extra-
membraneuse plus lupique que non lupique, mCme chez des malades
sans lupus erythCmateux disséminé cliniquement patent. Les valeurs
predictives positives/negatives de certaines des caracteristiques patho-
logiques étudiées sont les suivantes: depOts denses mésangiaux 63/99,
depOts denses sous-endothéliaux 77/93, inclusions tubuloréticulaires
61/96, depOts intenses de Clq 47/95, depOts dans Ia membrane basale
tubulaire 100/87, et hypercellularitC glomerulaire 26/86.
The characteristic light, immunofluorescence, and electron
microscopic features of membranous glomerulopathy (MG)
have been described thoroughly [lii. That MG occurs as one
variant of lupus nephritis is also well recognized [2]. In a patient
with clinically diagnosed systemic lupus erythematosus (SLE),
identification of MG in a renal biopsy is presumed to indicate a
common pathogenesis for the MG and SLE, thus leading to a
diagnosis of lupus MG (LMG).
Certain pathologic features are known to occur more fre-
quently in LMG than in nonlupus MG (NLMG) [31. However,
when these pathologic features suggesting LMG occur in a
patient with no clinical diagnosis of SLE, how accurately can
they identify those patients with unrecognized or nascent SLE?
To address this question, we determined how often selected
serologic, morphologic or immunohistopathologic features
were present in patients with MG who had (1) no clinical
diagnosis of SLE; (2) a diagnosis of SLE made at some interval
after biopsy or; (3) a diagnosis of SLE made during or before
the hospital admission when the biopsy was performed. The
features studied were serum antinuclear antibodies (AN A),
hypocomplementemia, glomerular hypercellularity, mesangial
dense deposits, subendothelial dense deposits, endothelial tu-
buloreticular inclusions, tubular basement membrane deposits,
biopsy tissue ANA reaction, and glomerular deposition of IgG,
IgA, 1gM, C3, C4, and Clq. These data were then used to
calculate the sensitivity, specificity, positive predictive value,
negative predictive value and overall efficiency of each serolog-
ic, morphologic, or immunohistopathologic feature in discrimi-
nating between NLMG and LMG.
Methods
Case selection. The working definition of MG used required
the ultrastructural identification of regularly distributed sub-
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epithelial dense deposits (or their stage 3 or 4 intramembranous
variants) without large subendothelial deposits. Unlike some
definitions of LMG that would relegate a MG patient with any
subendothelial deposits to a category of proliferative lupus
nephritis [4], small subendothelial deposits (Fig. 1) did not
exclude a patient from our MG series. And, in fact, most MG
patients with small subendothelial deposits had no glomerular
hypercellularity. Since the value of glomerular hypercellularity
in differentiating between LMG and NLMG was to be evaluat-
ed, this feature did not exclude a MG patient either. However,
patients with regularly distributed subepithelial deposits and
conspicuous subendothelial deposits were excluded from the
study. These patients often had diffuse hypercellularity and
characteristics of either diffuse proliferative, mixed membra-
nous and proliferative, or type 3 membranoproliferative
glomerulonephritis.
A total of 170 patients were studied. Although some patients
had repeat biopsies, only data from the first biopsy specimen
were used for compilation. One hundred forty-eight patients
found to have MG had no clinical diagnosis of SLE made before
or during the hospital admission when the biopsy was per-
formed. We evaluated followup clinical data on 78 of these
patients for an average of 25 months per patient (range, 4 to 92
months). Six of these 78 patients subsequently had SLE recog-
nized clinically after an average followup of 12 months. Twen-
ty-two patients had a clinical diagnosis of SLE made before or
during the hospital admission when the biopsy was performed.
Clinical data sought on all patients at the time of biopsy and
during followup included age, sex, number of American Rheu-
matism Association SLE criteria [5] observed, serum ANA,
and serum C3 level. By definition, all MG patients included in
this study had ultrastructural examination of glomeruli, 95%
had adequate glomeruli (10 or more) for light microscopic
evaluation, and 84% had glomeruli examined by immunofluo-
rescence microscopy.
Pathologic evaluation. Renal tissue samples for light micros-
copy were fixed in either buffered formalin or Helly's fixative.
Hematoxylin and eosin, periodic acid-Schiff and Jones' silver
methenamine stains were used routinely, and a Masson trich-
rome stain was also often used. For immunofluorescence
microscopy, tissue was either snap-frozen in liquid nitrogen or
held in Michel's solution [61 prior to snap-freezing. Cryostat
sections were reacted with fluorescein-labeled goat or rabbit
antibodies specific for human IgG, IgA, 1gM, C3, C4, or Clq
(Meloy Laboratories, Springfield, Virginia, or Calbiochem-
Behring, LaJolla, California) and viewed with a Leitz Orthoplan
or Dialux 20 microscope equipped for incident light fluores-
cence microscopy. Tissue samples for electron microscopy
were placed either in 2.5% phosphate-buffered glutaraldehyde
and postfixed in osmium tetroxide or primarily fixed in osmium
tetroxide. Epon 812 thin sections stained with lead citrate and
uranyl acetate were examined with a JEOL T-7 transmission
electron microscope.
Glomerular hypercellularity was evaluated independently by
two of the authors without knowledge of clinical, ultrastructur-
al, or immunohistologic data. The few discordant opinions were
resolved by review. Very slight focal segmental mesangial cell
clustering was not designated hypercellularity. The initial ultra-
structural examination of all cases was performed by one of the
authors. In all patients the presence of endothelial tubuloreticu-
lar inclusions and the locations of dense deposits were express-
ly sought and recorded in electron micrographs. To be designat-
ed mesangial, electron dense deposits had to be internal to a
recognizable paramesangial basement membrane (Fig. I). This
requirement was to prevent mistaken identification as mesan-
gial deposits tangentially cut subepithelial deposits or subepi-
thelial deposits on a majority of cases, one of the authors
evaluated contiguous capillary loops (Fig. 2). In a majority of
cases, one of the authors evaluated the initial immunofluores-
cence microscopic preparations, and in all other cases from
which immunofluorescence microscopic data were used, recuts
from the —70°C stored blocks were examined by the same
author. The degree of immunofluorescence was quantitated
from 0 to 4+.
Statistical analysis. To evaluate the diagnostic accuracy of
pathologic differentiation between LMG and NLMG the meth-
ods of Galen and Gambino [7] were applied. A determination
was designated a true positive (TP) if positive in a LMG patient,
a false positive (FP) if positive in a NLMG patient, a true
negative (TN) if negative in a NLMG patient, and a false
negative (FN) if negative in a LMG patient. The sensitivity (SN)
of a parameter is the incidence of TP results in LMG patients
[(TP) (TP + FN) x (100)] and is therefore equivalent to the
incidence of a given feature in LMG patients. The specificity
(SP) is the incidence of TN results in NLMG patients [(TN)
(TN + FP) x (100)]. The positive predictive value (PPV) is the
percent positive results that are true positives in the total
population of MG patients [(TP) ÷ (TP + FP) x (100)]. The
negative predictive value (NPV) is the percent negative results
that are true negatives in the total population of MG patients
[(TN) (TN + FN) x (100)]. The overall efficiency (EFF) for
differentiating between LMG and NLMG is the percent of all
results that are true results, whether positive or negative [(TP +
TN) ÷ (TP + FP + FN + TN) x (100)].
Results
Clinical data. The clinical data comparing the LMG and
NLMG patient groups are presented in Table 1. At the time of
biopsy, NLMG patients had a mean age of 42 (range, 8 to 78)
and a male to female ratio of 2:1. LMG patients had a somewhat
lower mean age of 30 (range, 9 to 64) and a reversal of the male
to female ratio to 1:4. Eighty-seven percent of LMG were black
while only 26% of NLMG patients were black. Ninety-one
percent of the NLMG patients had no more than one American
Rheumatism Association SLE criterion, whereas 96% of the
LMG patients had four or more criteria identified at the time a
clinical diagnosis of SLE was made. LMG patients with a
delayed diagnosis of SLE (latent SLE) had no more than two
SLE criteria at the time of biopsy, but all had four or more by
the time a diagnosis of SLE was made.
Serologic data. Hypocomplementemia was rare in NLMG
patients (2%) but was present in a majority of LMG patients
(65%) with overt LMG patients having a higher incidence (75%)
than latent LMG patients (33%). Although ANA were observed
in a few NLMG patients (7%), 100% of LMG patients had ANA
at the time a diagnosis of SLE was made. At the time of biopsy,
67% of latent LMG patients had ANA.
Morphologic data. Selected light and electron microscopic
data are presented in Table 2. Although glomerular hypercellu-
larity was approximately twice as frequent in LMG (27%)
compared to NLMG (15%), the difference was not statistically
significant (P > 0.1). Two NLMG patients with substantial
hypercellularity (Fig. 3) but no mesangial or subendothelial
deposits and no CIq or IgA by immunofluorescence microsco-
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Fig. 1. Electron micrograph of a glomerular capillary from a patient with lupus membranous glomeruloparhy. Numerous subepithelial electron
dense deposits (long straight arrow), small subendothelial electron dense deposits (short arrow) and mesangial deposits (curved arrow) subjacent to
the paramesangial basement membrane (diamond) are present. (x4,000)
py had repeat biopsies after 25 and 22 months, respectively,
showing the same pathologic features but still no clinical
evidence for SLE. Focal crescent formation and/or focal seg-
mental sclerosis were present in a few MG patients (3.5 and 4%,
respectively) but were not useful in distinguishing between
LMG and NLMG. One patient with NLMG with crescents had
simultaneous anti-GBM mediated injury [8]. There was no
difference in the frequency of ultrastructural stages [I] of dense
deposits between NLMG and LMG. Mesangial dense deposits,
small subendothelial dense deposits, tubuloreticular inclusions
(Fig. 4) and tubular basement membrane deposits (Fig. 5) all
had a statistically significant (P < 0.001) greater incidence in
LMG than NLMG patients. When present, tubuloreticular
inclusions were more conspicuous in LMG than NLMG. All of
these ultrastructural features were more frequent in overt than
latent LMG patients.
Immunohistopathologic data. Renal cortical tissue samples
were examined by immunofluorescence microscopy for glomer-
ular IgG, 1gM, IgA, C3, C4, and Clq. In almost all MG patients
IgG was the most intensely staining Ig, and only very rarely was
C3 more intense than IgG. In some LMG patients Clq staining
was equal to or greater than IgG staining in intensity. All
patients had diffuse global granular capillary wall deposits but
rare cases had segmentally variable capillary wall deposits. A
few patients, most often LMG patients, had different patterns of
staining with different antisera, for example, mesangial 1gM
Fig. 2. Diagram illustrating two different planes of section (open bars in
A and B) through two adjacent glomerular capillaries that would result
in ultrastructural semblances to electron dense deposits within mesan-
gial matrix (arrows in A' and B') although their true location was
subepithelial.
with capillary wall IgG. One patient with LMG had 3+ capillary
wall staining for IgG (4+ IgG4; no IgGi, IgG2, or IgG3) but no
capillary complement, and exclusively mesangial staining for
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Table 1. Clinical data from lupus and nonlupus membranous glomerulopathy patients
Mean age Sex ratio SLE Decreased
Group range M:F criteriaa serum C3
Serum
ANA
Nonlupus membranous glomerulopathy 8% 0
(N= 142) 42 2:1 83% 1 2% 7%(8to78) 8% 2
Lupus membranous glomerulopathy 4%h 3(N=28) 57% 4
30 1:4 25% 5 65% 100%"
(9to64) 7% 6
7% 7
Overt lupus membranous glomerulopathy 5% 3
(N=22) 59% 4
29 1:6 18% 5 75% 100%
(10to64) 9% 6
9% 7
Latent lupus membranous glomerulopathy 33/O%c 0(N = 6) 33/0% 1
32 1:1 33/0% 2 33% 67/100%c
(9 to 50) 0/50% 4
0/50% 5
The number of American Rheumatism Association criteria is cited.
b Percentage recorded at the time of clinical SLE diagnosis.
Percentage recorded at the time of biopsy/at the time of clinical SLE diagnosis.
Table 2. Morphologic data from lupus and nonlupus membranous glomerulopathy specimens
Glomerular Small sub- Tubulo-
hyper- EM Mesangial endothelial reticular TBMa
Group cellularity stage deposits deposits deposits deposits
Nonlupus membranous 18% I
glomerulopathy 15% 64% Il 11% 3% 10% 0%(N = 142) 12% III
6% IV
Lupus membranous gb- 14% 1
merulopathy (N = 28) 27% 68% II 96% 6l% 79% 32%
18% Ill
0% IV
Overt lupus membranous 14% 1
glomerulopathy 35% 68% II 100% 73% 82% 35%(N 22) 18% III
0% IV
Latent lupus membranous 17% I
glomerulopathy (N = 6) 0% 67% II 83% 17% 67% 20%
17% III
0% IV
Tubular basement membrane deposits were identified by electron or immunofluorescence microscopy.
C3, C4, Clq, and 1gM. One NLMG patient with mesangial
dense deposits and hypercellularity had exclusively capillary
wall IgG and exclusively mesangial IgA, Table 3 details the
incidence of positive staining in LMG and NLMG patients. The
incidence of glomerular IgG, 1gM, C3, and C4 deposition was
not significantly different (P > 0.1) between LMG and NLMG
patients, although the incidence of glomerular 1gM was some-
what higher in LMG patients. IgA deposition was twice as
frequent in LMG as NLMG patients (P > 0.05, < 0.1). The
difference between LMG and NLMG in the incidence of Clq
deposition was significant (P < 0.01) but became even more
significant (P < 0.001) if only intense (> or = 2+) staining was
considered. ANA bound to nuclei (Fig. 6) were observed in a
minority of LMG patients but never in NLMG patients. In
general patients with overt LMG showed a greater deviation
from the usual immunohistopathologic features of NLMG than
did patients with latent LMG but latent LMG gbomeruli did
show substantially more Clq staining than NLMG glomeruli.
Statistical analysis. Table 4 gives a compilation of the
diagnostic utility of the parameters studied for differentiating
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Fig. 3. Mesangial hypercellularity in a patient with nonlupus membra-
nous glomerulopathy. Hypercellularity was present in a repeat biopsy
25 months later. No mesangial or subendothelial dense deposits, IgA, or
Clq were observed in this patient. (hematoxylin and eosin, x300)
between NLMG and LMG. The values obtained are minimum
values since it is possible that within the NLMG group there are
patients who will eventually develop SLE, or who have,
unknown to us, developed SLE since the time of biopsy. The
pathologic features with the highest sensitivity for LMG versus
NLMG are serum ANA and mesangial dense deposits. Howev-
er, patients with latent LMG had serum ANA only 67% of the
time when biopsied although they all had ANA when a diagno-
sis of SLE was eventually made. Six of the features analyzed
had 90% or better specificity for LMG. TBM deposits and
tissue ANA had 100% specificity and therefore 100% positive
predictive value, but their low sensitivity decreased their over-
all diagnostic efficiency. In general, pathologic features had
better negative than positive predictive value, therefore making
their absence more useful in ruling out LMG than their presence
was in diagnosing LMG. Serum ANA was most efficient in
differentiating LMG from NLMG, followed in order by suben-
dothelial dense deposits, mesangial dense deposits, hypocom-
plementemia, endothelial tubuloreticular inclusions, tubular
basement membrane deposits, tissue ANA, and intense Clq
deposition. Glomerular deposits of IgA or combined IgG, IgA,
and 1gM, and glomerular hypercellularity were least efficient at
differentiating LMG from NLMG.
The simultaneous occurrence in MG patients of more than
one pathologic feature results in a greater specificity and
positive predictive value for LMG than would be the case for
the isolated occurrence of one of the features (lines (12), (13),
and (14) in Table 4). However, requiring more than one
parameter to be present before making a diagnosis of LMG
would reduce the sensitivity and negative predictive value of
the parameters.
Discussion
LMG differs from NLMG in clinical, serologic, morphologic,
and immunohistopathologic respects. In patients with definite
clinical evidence for SLE at the time of biopsy these distin-
guishing pathologic features of LMG are redundant for estab-
lishing a pathogenetic relationship between the MG and SLE.
Fig. 4. Electron micrograph of a glomerular capillary wall showing
supepithelial electron dense deposits (long arrow) and endothelial
tubuloreticular inclusions (short arrows). (x5,000)
Fig. 5 Electron micrograph showing tubular epithelial cells (long
arrow) and electron dense deposits (short arrow) within the tubular
basement membrane of a patient with lupus membranous gloinerulo-
pathy. (x5,000)
However, on occasion one or more of these features will be
observed in a patient with MG and without a clinical diagnosis
of SLE. The data presented in this publication were compiled in
an attempt to determine the relative accuracy of certain serolog-
ic, morphologic, and immunohistopathologic features for differ-
entiating between LMG and NLMG, and to offer some guid-
ance for predicting the likelihood that a patient with MG with
these features in fact has LMG rather than NLMG whether or
not clinical data are available to support this contention.
At the time SLE was diagnosed, 96% of our LMG patients
had four or more American Rheumatism Association lupus
criteria. Cohen and Canoso [51 found that 94% of SLE patients
fulfill four or more of these criteria. On the average, our LMG
patients were slightly younger and much more often female than
NLMG patients. A slight male preponderance in NLMG is well
documented in the literature [9, 10]. Marked predominance of
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Table 3. Immunohistopathologic data from lupus and nonlupus membranous glomerulopathy specimens
Immunohistopathologic feature
Group IgG 1gM IgA IgGMA C3 C4 CIq
2 +
Clq
Tissue
ANA
NLMG
LMG
Overt LMG
Latent LMG
99a(121/122)b
100 (21/21)
100 (16/16)
100 (5/5)
47(57/122)
62 (13/21)
75 (12/16)
20 (I/5)
16(20/122)
38 (8/21)
44 (7/16)
20 (1/5)
13(16/122)
29 (6/21)
37 (6/16)
0 (0/5)
85(103/121)
95 (20/21)
94 (15/16)
100 (5/5)
33(34/103)
47 (8/17)
43 (6/14)
67 (2/3)
23(18/78)
67 (8/12)
70 (7/10)
50 (1/2)
11(9/78)
67 (8/12)
70 (7/tO)
50 (1/2)
0(0/101)
17 (3/18)
20 (3/15)
0 (0/3)
Abbreviations: NLMG, nonlupus membranous glomerulopathy; LMG, lupus membranous glomerulopathy.
a The value represents percent of patients with a given immunopathologic feature.
b The value represents the number of patients positive/number of patients examined.
females with LMG was also reported by Baldwin et al (14 of 14
LMG were female) [21 and Appel et at (9 of 10 LMG were
female) [II]. Blacks accounted for 26% of NLMG patients as
compared with 87% of LMG. Our referral population (North
Carolina) has 22% blacks and our renal biopsy population as a
whole has 26% blacks. Appel et al [11] noted 70% of LMG
patients were black, although only 41% of all lupus glomenilo-
nephritis patients were black.
Only 2% of NLMG patients had hypocomplementemia com-
pared with 65% of LMG patients. Seventy-five percent of overt
LMG patients had hypocomplementemia. The frequency of
hypocomplementemia in NLMG patients has been reported to
be 3% [10] and 5% [12]. Hypocomplementemia was found in a
majority of LMG patients by Donadio, Burgess, and Holley [4]
and in 75% by Appel et at [11].
In our study, 7% of NLMG and 100% of LMG patients at the
time a diagnosis of SLE was made had ANA. Gaffney and
Panner [13] found no ANA in 41 patients with NLMG. ANA
were detected in 78% of LMG patients by Donadio, Burgess,
and Holley [4] and in 50% by Appel et al [I 1]. In our patients,
serum ANA had a very high negative predictive value, that is, if
absent, a diagnosis of SLE was unlikely. However, only 67% of
the latent LMG patients had serum ANA at the time MG was
first recognized, even though they eventually all demonstrated
ANA. Thus, no detectable serum ANA at the time of biopsy
does not eliminate eventual development of clinically overt
SLE. Although ANA are of low frequency in NLMG patients,
the small percentage of these patients with ANA results in a
disproportionate reduction in positive predictive value since the
NLMG group accounts for 84% of all MG patients. Although
less sensitive for LMG than serum ANA, hypocomplementemia
was more specific and thus had a higher positive predictive
value.
NLMG is usually considered to have no glomenilar hypercel-
lularity, albeit quantitative morphometry has revealed mesan-
gial hypercellularity [13, 14]. Some glomerular hypercellularity
has been noted in LMG and has been suggested to be of value in
differentiating between LMG and NLMG [2, 15]. In our pa-
tients, glomerular hypercellularity did occur more often in
LMG but was the least efficient parameter for differentiating
LMG from NLMG.
Mesangial electron dense deposits are common in LMG but
uncommon in NLMG [3]. We identified mesangial deposits in
11% of NLMG patients. In other series of NLMG patients
mesangial dense deposits were said to be present in 3% by
Gaffney and Panner [13], 8.5% by Shearn, Biana, and Hooper
Fig. 6. Direct immunofluorescence microscopy of renal biopsy tissue
from a patient with lupus membranous glomerulopa thy showing ANA
bound to tubular epithelial nuclei. (anti-IgG, x400)
[16], and 39% by Honig et al [17]. This latter study reported an
unusually high proportion of NLMG patients with mesangial
deposits and stated that these patients had atypical clinical
features compared with MG patients without mesangial depos-
its. We have some reservations about the validity of these data
since in our opinion their Figure 5 does not show mesangial
deposits but shows instead tangentially cut paramesangial sube-
pithelial deposits. Ninety-six percent of our LMG patients had
mesangial electron dense deposits. This agrees with the high
frequency of mesangial deposits observed in LMG by other
investigators [4, 11]. This high sensitivity for LMG results in the
highest negative predictive value for mesangial dense deposits
of any morphologic feature. That is, if mesangial dense deposits
are absent, SLE is not very likely in a MG patient. But the
positive predictive value of mesangial deposits is poor; thus,
strongly suggesting a diagnosis of LMG on the basis of these
deposits alone is unwarranted.
Small subendothelial electron dense deposits were identified
in 61% of biopsy specimens included in the LMG group. In
most patients these deposits were minute and few in number.
Patients with subendothelial deposits had no more glomerular
cellularity than patients without them. In one study of LMG,
Donadio, Burgess, and Holley [4] excluded SLE glomerulone-
phritis patients from the MG category if any subendothelial
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Table 4. Diagnostic accuracy of pathologic differentiation between lupus and nonlupus membranous glomerulopathy
Positive Negative
predictive predictive
Parameter Sensitivity Specificity value value Efficiency
(1) Serum ANA l00 93 78 100 94
(2) Hypocomplementemia 65 98 89 91 90
(3) Hypercellularity 27 85 26 86 76
(4) Mesangial deposits 96 89 63 99 90
(5) Subendothelial deposits 61 96 77 93 91
(6) Tubuloreticular inclusions 79 90 61 96 88
(7) TBM deposits 32 100 100 87 88
(8) IgA deposits 38 84 29 89 77
(9) IgGMA deposits 29 87 27 88 78
(10) Intense Clq 67 88 47 95 86
(11) Tissue ANA 17 100 100 87 87
(12) (4) and (6)" 79 96 81 96 94
(13) (4), (5) and (6) 50 99 88 91 91
(14) (2), (4), (5) and (6) 46 100 100 86 88
Serum ANA were present in 67% of latent lupus patients at the time of biopsy but in 100% when a diagnosis of lupus was made.
b These data represent combined parameters.
Table 5. Clinical and pathologic data on six patients with latent lupus membranous glomerulopathy
Glomerular Mesangial Tubulore- Subendo-
SLE Latent Decreased hyper- dense ticular thelial IgA Clq
Age Sex criteria penodb ANAC serum C3c cellularity deposits inclusions deposits deposits deposits
32 F 0/4 4 + 0 0 + + 0 Nd N
50 F 0/5 18 0 + 0 + + 0 0 N
9 M 1/5 7 + + 0 + + 0 0 N
42 M 2/5 23 + 0 0 + 0 + 0 N
44 M 2/4 16 + 0 0 + + 0 0 0
16 F 1/4 4 0 0 0 0 + 0 + +
The value represents at the time of biopsy/at the time of SLE diagnosis.
b The period consists of time in months between biopsy and SLE diagnosis.
Data was taken at the time of biopsy.
d N = not done.
deposits were present, although in another publication Donadio
and Holley [18] acknowledged the presence of subendothelial
deposits in some patients with LMG. Other investigators have
also noted the occurrence of subendothelial electron dense
deposits in LMG [11, 19]. In our patients, subendothelial
deposits were more frequent in patients with overt (73%) rather
than latent (17%) SLE.
The high frequency of tubuloreticular inclusions (TRI) in
lupus glomerulonephritis compared with other glomerulopath-
ies is well known [20—26]. TRI were identified in 79% of our
LMG patients. During the interval of study reported in this
publication we identified TRI in 93% of 61 lupus glomerulone-
phritis patients not categorized as LMG. Therefore, although
frequent in LMG, TRI are more frequent in the proliferative
variants of lupus glomerulonephritis. TRI were identified in
10% of our NLMG specimens. The combined data from four
reports in the literature indicate 5%(9of 186) of NLMG patients
with TRI [20, 22, 25, 27].
Tubular basement membrane (TBM) deposits are common in
lupus glomerulonephritis but rarely found in NLMG [3]. We
identified TBM deposits in 32% of LMG biopsy specimens but
0% of NLMG biopsy specimens. Lehman, Wilson, and Dixon
[28] found 56% (18 of 32) of lupus glomerulonephritis patients to
have granular TBM deposits by immunofluorescence microsco-
py, but none of 26 MG specimens had TBM deposits. Brentjens
et al [29] noted by immunofluorescence microscopy TBM
deposits in 53% of lupus glomerulonephritis patients. However,
while 66% of diffuse proliferative lupus glomerulonephritis
patients had TBM deposits, only 40% of LMG patients had
deposits. They saw one of 34 NLMG biopsy specimens demon-
strating TBM deposits by immunofluorescence microscopy, but
this was not confirmed by electron microscopy. TBM deposits
are therefore very specific for LMG and have a high positive
predictive value, but they are insensitive and therefore have an
overall diagnostic efficiency of less than 90%.
By immunofluorescence microscopy there was no statistical-
ly significant (P> 0.1) difference between LMG and NLMG in
the frequency of IgG, 1gM, C3, or C4 glomerular deposition.
IgA and Clq occurred at a significantly higher frequency in
LMG, but the frequency of intense (2+ or more) Clq deposition
was most significantly (P < 0.001) elevated in LMG compared
with NLMG. Such high intensity Clq staining has been report-
ed previously in lupus glomerulonephritis and may result from
binding of Clq to DNA as well as to Ig [30].
Immunoglobulins, presumably ANA, bound to nuclei in the
biopsy specimen were noted in 17% of LMG patients (only in
overt SLE patients) compared with 0% of NLMG biopsy
specimens. The nuclear staining usually had a speckled pattern.
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McCoy [31] observed tissue ANA in 32% (6 of 19) of SLE
glomerulonephritis biopsy specimens, including three LMG
patients but saw no tissue ANA in any of 225 renal biopsy
specimens from patients who did not have SLE. Therefore,
tissue ANA has 100% specificity and positive predictive value
for LMG but very low sensitivity.
In one series of 150 SLE patients, 6% presented with renal
disease, usually nephrotic syndrome, as the initial manifesta-
tion [32]. Reported in the literature are 12 patients with MG and
no clinical evidence for SLE who subsequently developed overt
SLE after 5 months to 7 years [22, 33—37]. Many of these
patients were noted to have endothelial TRI in the initial biopsy
tissue sample. Six of our LMG patients did not exhibit clinical
evidence for SLE at the time of biopsy, but were later found to
have SLE after an average interval of 1 year (Table 5). These
patients with latent SLE had a lower incidence of hypocomple-
mentemia and serum ANA than overt SLE patients, and the
frequency in them of the morphologic and immunohistopatholo-
gic parameters analyzed tended to be intermediate relative to
NLMG and overt LMG, but usually more closely approximated
the overt LMG values. All patients with latent LMG had at least
two of the following features: TRI, mesangial dense deposits,
small subendothelial dense deposits, or intense Clq. Therefore,
although clinical evidence for SLE was lacking at the time of
biopsy, there was pathologic evidence suggesting LMG rather
than NLMG in all six patients with latent LMG.
In general, the serologic, morphologic, and immunohisto-
pathologic features analyzed were better at ruling out SLE than
making a diagnosis of LMG. This is indicated by six parameters
having negative predictive values greater than 90% as compared
with only two parameters (both of very low sensitivity) having
positive predictive values greater than 90%. However, the
significantly different incidence in LMG versus NLMG of a
number of these features warrants suggesting the possibility of
unrecognized or nascent SLE in certain patients found to have
MG displaying these features. In addition, the specificity and
positive predictive value of pathologic features increases when,
as is often the case, more than one is observed in a given biopsy
specimen. However, since requiring the presence of multiple
parameters before making a diagnosis of LMG would reduce
the sensitivity and negative predictive values of the parameters,
the overall diagnostic efficiency for discriminating between
LMG and NLMG would not be altered significantly. But, for
individual cases, the simultaneous occurrence of multiple
pathologic features with some degree of specificity for LMG
substantially enhances the positive predictive values for LMG.
Therefore, from our data, although individually, mesangial
dense deposits, subendothelial dense deposits, and tubuloreti-
cular inclusions have positive predictive values of 61 to 77, the
simultaneous occurrence of these three parameters results in a
positive predictive value of 88 and increases to 100 if hypocom-
plementemnia is also present.
Reprint requests to Dr. J. C. Jennette, Immunopathology Labora-
tory, Department of Pathology, School of Medicine, University of
North Carolina, Chapel Hill, North Carolina 27514, USA
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